Menu
GeneBe

5-54171882-T-A

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate

The NM_019087.3(ARL15):c.95A>T(p.Glu32Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

ARL15
NM_019087.3 missense

Scores

8
8
3

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.98
Variant links:
Genes affected
ARL15 (HGNC:25945): (ADP ribosylation factor like GTPase 15) Predicted to enable GTP binding activity and GTPase activity. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.862

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ARL15NM_019087.3 linkuse as main transcriptc.95A>T p.Glu32Val missense_variant 2/5 ENST00000504924.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ARL15ENST00000504924.6 linkuse as main transcriptc.95A>T p.Glu32Val missense_variant 2/51 NM_019087.3 P1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 31, 2024The c.95A>T (p.E32V) alteration is located in exon 2 (coding exon 2) of the ARL15 gene. This alteration results from a A to T substitution at nucleotide position 95, causing the glutamic acid (E) at amino acid position 32 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.69
BayesDel_addAF
Pathogenic
0.30
D
BayesDel_noAF
Pathogenic
0.19
Cadd
Pathogenic
29
Dann
Uncertain
0.99
DEOGEN2
Benign
0.22
T;T;.
Eigen
Uncertain
0.68
Eigen_PC
Pathogenic
0.68
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.92
D;D;D
M_CAP
Uncertain
0.11
D
MetaRNN
Pathogenic
0.86
D;D;D
MetaSVM
Uncertain
-0.056
T
MutationAssessor
Pathogenic
3.0
M;.;.
MutationTaster
Benign
1.0
D
PrimateAI
Pathogenic
0.84
D
PROVEAN
Uncertain
-4.4
D;.;D
REVEL
Pathogenic
0.66
Sift
Benign
0.046
D;.;D
Sift4G
Uncertain
0.0050
D;D;D
Polyphen
0.89
P;.;.
Vest4
0.88
MutPred
0.64
Loss of catalytic residue at E32 (P = 0.0348);Loss of catalytic residue at E32 (P = 0.0348);Loss of catalytic residue at E32 (P = 0.0348);
MVP
0.82
MPC
0.86
ClinPred
0.99
D
GERP RS
5.9
Varity_R
0.41
gMVP
0.79

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr5-53467712; API